Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Chondrosarcoma × Curettage × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Basal Cell 4 Chalazion 2 Recurrence 1 Pilonidal Sinus 1 Pain 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 Chondrosarcoma 1 Chondroma 1 Carcinoma, Squamous Cell 1 Bone Neoplasms 1 Bone Cysts 1

Interventions

Proton Therapy 3 Filgrastim 3 Docetaxel 3 regorafenib 2 Sunitinib 2 Ifosfamide 2 Gemcitabine 2 temsirolimus 1 pegfilgrastim 1 liposomal doxorubicin 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 ivosidenib 1 itacitinib 1 etoposide phosphate 1 capivasertib 1 baricitinib 1 angiotensin I (1-7) 1 abemaciclib 1 Zoledronic Acid 1 Weight-Bearing 1 Trabectedin 1 Thalidomide 1 Taxes 1 TQ-B3525 1 Surveys and Questionnaires 1 Standard of Care 1 Range of Motion, Articular 1 Radiotherapy 1 Peripheral Blood Stem Cell Transplantation 1 Pentetic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02996747 2016-12-22

CONDRO1

Istituto Ortopedico Rizzoli

Bone Neoplasms, Chondroma, Chondrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡